Senior Medical Director
Phase II Psychiatry Biotech, Europe
The Challenge:
A small but rapidly growing biotechnology company developing therapies for treatment-resistant depression and bipolar disorder was preparing for an upcoming Phase II clinical trial. Having recently placed their Chairperson, the client turned to us to identify a hands-on Senior Medical Director with deep expertise in psychiatry and clinical development.
The challenge was twofold:
The company required a seasoned psychiatry specialist capable of leading European clinical strategy and medical oversight.
Timelines were extremely tight, demanding an efficient and structured process to meet internal program milestones.
Our Approach:
We worked on a contingent basis, partnering closely with the clinical leadership team. To maintain speed, we established a three-stage interview process with pre-booked interview slots, ensuring no scheduling delays. Leveraging our extensive CNS and psychiatric medical network, we delivered a shortlist of five highly qualified candidates within 10 days, all with relevant medical specialty training and Phase I-III clinical development experience.
The Outcome:
Apsida coordinated interviews with the top three candidates, each demonstrating the clinical, regulatory, and medical monitoring experience required for Phase II execution. The client extended an offer to their lead candidate immediately, who accepted without hesitation. The new Senior Medical Director is now leading European clinical development strategy, medical monitoring, and cross-functional medical support for the Phase II program.